View:

Download DOC

Download PDF

United States securities and exchange commission logo





                 May 31, 2022

       Sharon Malka
       Chief Executive Officer
       MediWound Ltd.
       42 Hayarkon Street
       Yavne 8122745, Israel

                                                        Re: MediWound Ltd.
                                                            Registration
Statement on Form F-3
                                                            Filed May 25, 2022
                                                            File No. 333-265203

       Dear Ms. Malka:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

              Please contact Michael Davis at 202-551-4385 or Joe McCann at
202-551-6262 with any
       questions.




                 Sincerely,


                 Division of Corporation Finance

                 Office of Life Sciences
       cc:                                              Michael Rosenberg